+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Patient Derived Xenograft/PDX Models - Global Market Trajectory & Analytics

  • ID: 4845767
  • Report
  • June 2020
  • Region: Global
  • 164 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Champions Oncology
  • Crown Bioscience
  • Epo Berlin-Buch GMBH
  • Hera Biolabs
  • Oncodesign
  • Pharmatest Services Ltd.
  • MORE
Amid the COVID-19 crisis and the looming economic recession, the Patient Derived Xenograft/PDX Models market worldwide will grow by a projected US $207.6, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 19%. Mouse, one of the segments analyzed and sized in this study, is forecast to grow at over 18% and reach a market size of US $197.6 by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Mouse market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 18% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US $7.1 to the region's size over the next 7 to 8 years. In addition, over US $8.8 worth of projected demand in the region will come from Rest of European markets. In Japan, the Mouse segment will reach a market size of US $10.6 by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Patient Derived Xenograft/PDX Models market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 16.6% over the next couple of years and add approximately US $25.8 in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Patient Derived Xenograft/PDX Models market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others are:
  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Epo Berlin-Buch GmbH
  • Hera BioLabs
  • Oncodesign
  • Pharmatest Services Ltd.
  • The Jackson Laboratory
  • Urolead SAS
  • WuXi AppTec
  • Xentech

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Champions Oncology
  • Crown Bioscience
  • Epo Berlin-Buch GMBH
  • Hera Biolabs
  • Oncodesign
  • Pharmatest Services Ltd.
  • MORE
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Patient Derived Xenograft/PDX Models Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Patient Derived Xenograft/PDX Models Global Market Estimates and Forecasts in US$ by Region/Country: 2020-2027
TABLE 2: Patient Derived Xenograft/PDX Models Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
TABLE 3: Mouse (Type) World Market by Region/Country in US$: 2020 to 2027
TABLE 4: Mouse (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
TABLE 5: Rat (Type) Potential Growth Markets Worldwide in US$: 2020 to 2027
TABLE 6: Rat (Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
TABLE 7: Pre-Clinical Drug Development (Application) Global Market Estimates & Forecasts in US$ by Region/Country: 2020-2027
TABLE 8: Pre-Clinical Drug Development (Application) Market Share Breakdown by Region/Country: 2020 VS 2027
TABLE 9: Basic Cancer Research (Application) Demand Potential Worldwide in US$ by Region/Country: 2020-2027
TABLE 10: Basic Cancer Research (Application) Share Breakdown Review by Region/Country: 2020 VS 2027
TABLE 11: Pharma & Biotech (End-Use) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2020-2027
TABLE 12: Pharma & Biotech (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027
TABLE 13: CRO (End-Use) Sales Estimates and Forecasts in US$ by Region/Country for the Years 2020 through 2027
TABLE 14: CRO (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027

III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Patient Derived Xenograft/PDX Models Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 15: United States Patient Derived Xenograft/PDX Models Market Estimates and Projections in US$ by Type: 2020 to 2027
TABLE 16: United States Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
TABLE 17: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by Application: 2020 to 2027
TABLE 18: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by Application: 2020 VS 2027
TABLE 19: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by End-Use: 2020 to 2027
TABLE 20: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by End-Use: 2020 VS 2027
CANADA
TABLE 21: Canadian Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020 to 2027
TABLE 22: Patient Derived Xenograft/PDX Models Market in Canada: Percentage Share Breakdown of Sales by Type for 2020 and 2027
TABLE 23: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
TABLE 24: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
TABLE 25: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
TABLE 26: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
JAPAN
TABLE 27: Japanese Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2020-2027
TABLE 28: Japanese Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
TABLE 29: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
TABLE 30: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by Application: 2020 VS 2027
TABLE 31: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
TABLE 32: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by End-Use: 2020 VS 2027
CHINA
TABLE 33: Chinese Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2020-2027
TABLE 34: Chinese Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2020 and 2027
TABLE 35: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
TABLE 36: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2020 VS 2027
TABLE 37: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
TABLE 38: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2020 VS 2027
EUROPE
Market Facts & Figures
European Patient Derived Xenograft/PDX Models Market: Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
TABLE 39: European Patient Derived Xenograft/PDX Models Market Demand Scenario in US$ by Region/Country: 2018-2025
TABLE 40: European Patient Derived Xenograft/PDX Models Market Share Shift by Region/Country: 2020 VS 2027
TABLE 41: European Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020-2027
TABLE 42: European Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
TABLE 43: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2020-2027
TABLE 44: European Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
TABLE 45: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2020-2027
TABLE 46: European Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
FRANCE
TABLE 47: Patient Derived Xenograft/PDX Models Market in France by Type: Estimates and Projections in US$ for the Period 2020-2027
TABLE 48: French Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
TABLE 49: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by Application: 2020-2027
TABLE 50: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
TABLE 51: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by End-Use: 2020-2027
TABLE 52: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
GERMANY
TABLE 53: Patient Derived Xenograft/PDX Models Market in Germany: Recent Past, Current and Future Analysis in US$ by Type for the Period 2020-2027
TABLE 54: German Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
TABLE 55: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by Application for the Period 2020-2027
TABLE 56: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by Application: 2020 VS 2027
TABLE 57: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by End-Use for the Period 2020-2027
TABLE 58: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by End-Use: 2020 VS 2027
ITALY
TABLE 59: Italian Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2020-2027
TABLE 60: Italian Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2020 and 2027
TABLE 61: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
TABLE 62: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2020 VS 2027
TABLE 63: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
TABLE 64: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2020 VS 2027
UNITED KINGDOM
TABLE 65: United Kingdom Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2020-2027
TABLE 66: United Kingdom Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
TABLE 67: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
TABLE 68: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by Application: 2020 VS 2027
TABLE 69: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
TABLE 70: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
REST OF EUROPE
TABLE 71: Rest of Europe Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020-2027
TABLE 72: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
TABLE 73: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2020-2027
TABLE 74: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
TABLE 75: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2020-2027
TABLE 76: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
ASIA-PACIFIC
TABLE 77: Patient Derived Xenograft/PDX Models Market in Asia-Pacific by Type: Estimates and Projections in US$ for the Period 2020-2027
TABLE 78: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
TABLE 79: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by Application: 2020-2027
TABLE 80: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
TABLE 81: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use: 2020-2027
TABLE 82: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
REST OF WORLD
TABLE 83: Rest of World Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020 to 2027
TABLE 84: Patient Derived Xenograft/PDX Models Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2020 and 2027
TABLE 85: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
TABLE 86: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
TABLE 87: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
TABLE 88: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 38
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Champions Oncology
  • Charles River Laboratories International
  • Crown Bioscience
  • Epo Berlin-Buch GMBH
  • Hera Biolabs
  • Oncodesign
  • Pharmatest Services Ltd.
  • the Jackson Laboratory
  • Urolead Sas
  • Wuxi Apptec
  • Xentech
Note: Product cover images may vary from those shown
Adroll
adroll